Logo image of REPX

RILEY EXPLORATION PERMIAN IN (REPX) Stock Fundamental Analysis

NYSEARCA:REPX - NYSE Arca - US76665T1025 - Common Stock - Currency: USD

25.42  -1.81 (-6.65%)

After market: 25.42 0 (0%)

Fundamental Rating

6

Taking everything into account, REPX scores 6 out of 10 in our fundamental rating. REPX was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. While REPX has a great profitability rating, there are some minor concerns on its financial health. REPX may be a bit undervalued, certainly considering the very reasonable score on growth This makes REPX very considerable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

REPX had positive earnings in the past year.
REPX had a positive operating cash flow in the past year.
In multiple years REPX reported negative net income over the last 5 years.
Of the past 5 years REPX 4 years had a positive operating cash flow.
REPX Yearly Net Income VS EBIT VS OCF VS FCFREPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

REPX has a Return On Assets of 9.93%. This is amongst the best in the industry. REPX outperforms 82.86% of its industry peers.
REPX has a better Return On Equity (18.55%) than 79.52% of its industry peers.
Looking at the Return On Invested Capital, with a value of 17.08%, REPX belongs to the top of the industry, outperforming 92.38% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for REPX is in line with the industry average of 23.80%.
The last Return On Invested Capital (17.08%) for REPX is well below the 3 year average (23.68%), which needs to be investigated, but indicates that REPX had better years and this may not be a problem.
Industry RankSector Rank
ROA 9.93%
ROE 18.55%
ROIC 17.08%
ROA(3y)14.55%
ROA(5y)-8.31%
ROE(3y)26.42%
ROE(5y)-17.08%
ROIC(3y)23.68%
ROIC(5y)N/A
REPX Yearly ROA, ROE, ROICREPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

The Profit Margin of REPX (23.92%) is better than 76.19% of its industry peers.
The Operating Margin of REPX (47.39%) is better than 89.05% of its industry peers.
REPX's Operating Margin has improved in the last couple of years.
REPX has a Gross Margin of 75.32%. This is amongst the best in the industry. REPX outperforms 86.19% of its industry peers.
REPX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 47.39%
PM (TTM) 23.92%
GM 75.32%
OM growth 3Y4.43%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.84%
GM growth 5Y19.4%
REPX Yearly Profit, Operating, Gross MarginsREPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), REPX is creating value.
Compared to 1 year ago, REPX has more shares outstanding
The number of shares outstanding for REPX has been increased compared to 5 years ago.
Compared to 1 year ago, REPX has an improved debt to assets ratio.
REPX Yearly Shares OutstandingREPX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
REPX Yearly Total Debt VS Total AssetsREPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

REPX has an Altman-Z score of 2.02. This is not the best score and indicates that REPX is in the grey zone with still only limited risk for bankruptcy at the moment.
REPX's Altman-Z score of 2.02 is fine compared to the rest of the industry. REPX outperforms 68.10% of its industry peers.
The Debt to FCF ratio of REPX is 1.97, which is an excellent value as it means it would take REPX, only 1.97 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of REPX (1.97) is better than 83.33% of its industry peers.
A Debt/Equity ratio of 0.43 indicates that REPX is not too dependend on debt financing.
The Debt to Equity ratio of REPX (0.43) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 1.97
Altman-Z 2.02
ROIC/WACC1.7
WACC10.04%
REPX Yearly LT Debt VS Equity VS FCFREPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 0.44 indicates that REPX may have some problems paying its short term obligations.
REPX has a Current ratio of 0.44. This is amonst the worse of the industry: REPX underperforms 88.10% of its industry peers.
A Quick Ratio of 0.41 indicates that REPX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.41, REPX is doing worse than 87.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.41
REPX Yearly Current Assets VS Current LiabilitesREPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

REPX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.98%, which is quite impressive.
REPX shows a small growth in Revenue. In the last year, the Revenue has grown by 1.25%.
REPX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 142.30% yearly.
EPS 1Y (TTM)23.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.68%
Revenue 1Y (TTM)1.25%
Revenue growth 3Y39.52%
Revenue growth 5Y142.3%
Sales Q2Q%2.72%

3.2 Future

The Earnings Per Share is expected to grow by 5.88% on average over the next years.
The Revenue is expected to grow by 2.30% on average over the next years.
EPS Next Y14.21%
EPS Next 2Y13.71%
EPS Next 3Y5.88%
EPS Next 5YN/A
Revenue Next Year0.93%
Revenue Next 2Y2.48%
Revenue Next 3Y2.3%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
REPX Yearly Revenue VS EstimatesREPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
REPX Yearly EPS VS EstimatesREPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2 4 6

9

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.17, the valuation of REPX can be described as very cheap.
Based on the Price/Earnings ratio, REPX is valued cheaper than 93.81% of the companies in the same industry.
REPX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.18.
Based on the Price/Forward Earnings ratio of 3.46, the valuation of REPX can be described as very cheap.
Based on the Price/Forward Earnings ratio, REPX is valued cheaper than 96.67% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.34, REPX is valued rather cheaply.
Industry RankSector Rank
PE 4.17
Fwd PE 3.46
REPX Price Earnings VS Forward Price EarningsREPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of REPX indicates a rather cheap valuation: REPX is cheaper than 88.10% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, REPX is valued cheaply inside the industry as 91.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.42
EV/EBITDA 2.94
REPX Per share dataREPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
REPX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y13.71%
EPS Next 3Y5.88%

6

5. Dividend

5.1 Amount

REPX has a Yearly Dividend Yield of 5.49%, which is a nice return.
Compared to an average industry Dividend Yield of 6.41, REPX pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, REPX pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.49%

5.2 History

REPX has been paying a dividend for over 5 years, so it has already some track record.
REPX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
REPX Yearly Dividends per shareREPX Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

32.09% of the earnings are spent on dividend by REPX. This is a low number and sustainable payout ratio.
DP32.09%
EPS Next 2Y13.71%
EPS Next 3Y5.88%
REPX Yearly Income VS Free CF VS DividendREPX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M
REPX Dividend Payout.REPX Dividend Payout, showing the Payout Ratio.REPX Dividend Payout.PayoutRetained Earnings

RILEY EXPLORATION PERMIAN IN

NYSEARCA:REPX (7/15/2025, 8:19:02 PM)

After market: 25.42 0 (0%)

25.42

-1.81 (-6.65%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners52.55%
Inst Owner Change0%
Ins Owners5.12%
Ins Owner Change9.41%
Market Cap559.75M
Analysts82.22
Price Target57.97 (128.05%)
Short Float %3.03%
Short Ratio3.91
Dividend
Industry RankSector Rank
Dividend Yield 5.49%
Yearly Dividend1.47
Dividend Growth(5Y)N/A
DP32.09%
Div Incr Years3
Div Non Decr Years3
Ex-Date04-24 2025-04-24 (0.38)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-41.66%
Min EPS beat(2)-68.25%
Max EPS beat(2)-15.07%
EPS beat(4)1
Avg EPS beat(4)-7.46%
Min EPS beat(4)-68.25%
Max EPS beat(4)63.95%
EPS beat(8)2
Avg EPS beat(8)-17.4%
EPS beat(12)5
Avg EPS beat(12)-14.31%
EPS beat(16)5
Avg EPS beat(16)-31.46%
Revenue beat(2)0
Avg Revenue beat(2)-1.71%
Min Revenue beat(2)-1.72%
Max Revenue beat(2)-1.7%
Revenue beat(4)0
Avg Revenue beat(4)-2.3%
Min Revenue beat(4)-3.19%
Max Revenue beat(4)-1.7%
Revenue beat(8)4
Avg Revenue beat(8)1.49%
Revenue beat(12)8
Avg Revenue beat(12)41.49%
Revenue beat(16)12
Avg Revenue beat(16)38.85%
PT rev (1m)0%
PT rev (3m)8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.65%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-3.78%
Revenue NQ rev (3m)-7.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.55%
Valuation
Industry RankSector Rank
PE 4.17
Fwd PE 3.46
P/S 1.36
P/FCF 4.42
P/OCF 2.33
P/B 1.05
P/tB 1.05
EV/EBITDA 2.94
EPS(TTM)6.1
EY24%
EPS(NY)7.34
Fwd EY28.89%
FCF(TTM)5.75
FCFY22.6%
OCF(TTM)10.92
OCFY42.97%
SpS18.75
BVpS24.18
TBVpS24.18
PEG (NY)0.29
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.93%
ROE 18.55%
ROCE 22.41%
ROIC 17.08%
ROICexc 17.25%
ROICexgc 17.25%
OM 47.39%
PM (TTM) 23.92%
GM 75.32%
FCFM 30.64%
ROA(3y)14.55%
ROA(5y)-8.31%
ROE(3y)26.42%
ROE(5y)-17.08%
ROIC(3y)23.68%
ROIC(5y)N/A
ROICexc(3y)24.26%
ROICexc(5y)N/A
ROICexgc(3y)24.26%
ROICexgc(5y)N/A
ROCE(3y)31.08%
ROCE(5y)N/A
ROICexcg growth 3Y1.22%
ROICexcg growth 5YN/A
ROICexc growth 3Y1.22%
ROICexc growth 5YN/A
OM growth 3Y4.43%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.84%
GM growth 5Y19.4%
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 1.97
Debt/EBITDA 0.84
Cap/Depr 149.51%
Cap/Sales 27.61%
Interest Coverage 6.72
Cash Conversion 88.45%
Profit Quality 128.09%
Current Ratio 0.44
Quick Ratio 0.41
Altman-Z 2.02
F-Score4
WACC10.04%
ROIC/WACC1.7
Cap/Depr(3y)429.72%
Cap/Depr(5y)307.72%
Cap/Sales(3y)65.26%
Cap/Sales(5y)47.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.68%
EPS Next Y14.21%
EPS Next 2Y13.71%
EPS Next 3Y5.88%
EPS Next 5YN/A
Revenue 1Y (TTM)1.25%
Revenue growth 3Y39.52%
Revenue growth 5Y142.3%
Sales Q2Q%2.72%
Revenue Next Year0.93%
Revenue Next 2Y2.48%
Revenue Next 3Y2.3%
Revenue Next 5YN/A
EBIT growth 1Y-2.22%
EBIT growth 3Y45.7%
EBIT growth 5YN/A
EBIT Next Year63.14%
EBIT Next 3Y19.44%
EBIT Next 5YN/A
FCF growth 1Y359.85%
FCF growth 3Y65.66%
FCF growth 5YN/A
OCF growth 1Y58.73%
OCF growth 3Y41.96%
OCF growth 5Y305.01%